Free Trial

Corteva (CTVA) Stock Forecast & Price Target

$57.85
-0.15 (-0.26%)
(As of 09/24/2024 ET)

Corteva - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
1
Hold
6
Buy
13

Based on 20 Wall Street analysts who have issued ratings for Corteva in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 20 analysts, 1 has given a sell rating, 6 have given a hold rating, and 13 have given a buy rating for CTVA.

Consensus Price Target

$61.94
7.08% Upside
According to the 20 analysts' twelve-month price targets for Corteva, the average price target is $61.94. The highest price target for CTVA is $69.00, while the lowest price target for CTVA is $52.00. The average price target represents a forecasted upside of 7.08% from the current price of $57.85.
Get the Latest News and Ratings for CTVA and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Corteva and its competitors.

Sign Up

CTVA Analyst Ratings Over Time

TypeCurrent Forecast
9/26/23 to 9/25/24
1 Month Ago
8/27/23 to 8/26/24
3 Months Ago
6/28/23 to 6/27/24
1 Year Ago
9/26/22 to 9/26/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
13 Buy rating(s)
13 Buy rating(s)
15 Buy rating(s)
15 Buy rating(s)
Hold
6 Hold rating(s)
6 Hold rating(s)
6 Hold rating(s)
4 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$61.94$61.67$63.00$70.41
Forecasted Upside7.08% Upside10.81% Upside17.38% Upside38.58% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

CTVA Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CTVA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Corteva Stock vs. The Competition

TypeCortevaConsumer Staples CompaniesS&P 500
Consensus Rating Score
2.60
2.45
2.50
Consensus RatingModerate BuyHoldHold
Predicted Upside7.08% Upside629.59% Upside6.80% Upside
News Sentiment Rating
Positive News

See Recent CTVA News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
9/24/2024Morgan Stanley
3 of 5 stars
 Reiterated RatingOverweight ➝ Overweight$65.00 ➝ $65.00+12.67%
8/7/2024Argus
3 of 5 stars
W. Selesky
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold
8/2/2024JPMorgan Chase & Co.
3 of 5 stars
 Lower TargetNeutral ➝ Neutral$57.00 ➝ $55.00+6.63%
8/2/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$67.00 ➝ $65.00+26.07%
8/2/2024KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$66.00 ➝ $62.00+20.06%
6/18/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$61.00 ➝ $60.00+15.27%
6/12/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$65.00 ➝ $65.00+25.90%
6/7/2024OTR Global
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMixed ➝ Negative
5/6/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$62.00 ➝ $64.00+12.89%
5/3/2024Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$60.00 ➝ $65.00+13.72%
5/3/2024BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$64.00 ➝ $67.00+17.13%
5/3/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$67.00 ➝ $69.00+21.52%
4/10/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$55.00 ➝ $58.00+1.42%
3/1/2024Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$67.00+25.30%
2/12/2024Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$57.00 ➝ $65.00+21.27%
2/2/2024BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderperform ➝ Neutral$53.00-1.96%
1/11/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$65.00 ➝ $64.00+38.77%
11/27/2023Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$63.00 ➝ $52.00+11.42%
11/22/2023Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$82.00 ➝ $63.00+36.45%
10/24/2023The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$65.00 ➝ $56.00+15.08%
8/4/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$74.00+31.95%
7/25/2023Redburn Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral
5/22/2023VNET Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingUpgrade
5/22/2023Vertical Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$67.00+17.61%
2/3/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$72.00 ➝ $74.00+19.35%
1/11/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderperform ➝ Neutral$64.00 ➝ $68.00+10.12%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 06:29 AM ET.


Should I Buy Corteva Stock? CTVA Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, September 19, 2024. Please send any questions or comments about these Corteva pros and cons to contact@marketbeat.com.

Corteva
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Corteva, Inc.:

  • Corteva's stock price has shown a positive trend, trading up recently to $55.33, indicating potential growth.
  • Analysts have given Corteva a consensus rating of "Moderate Buy" with a price target of $61.67, suggesting optimism in the stock.
  • Institutional investors like Mediolanum International Funds Ltd have been increasing their stakes in Corteva, indicating confidence in the company's future performance.
  • Wall Street analysts have mostly issued buy ratings for Corteva, with price targets above the current trading price, signaling a positive outlook.
  • Corteva's market capitalization of $38.56 billion and strong financial ratios like a current ratio of 1.72 and a quick ratio of 1.17 demonstrate stability and potential for growth.

Corteva
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Corteva, Inc. for these reasons:

  • Despite positive analyst ratings, there is a risk associated with the stock's high price-to-earnings ratio of 70.04, which may indicate overvaluation.
  • Recent analyst reports have included a negative rating on Corteva, suggesting some concerns about the company's performance or market conditions.
  • While institutional investors have been increasing their stakes, there is a possibility of market volatility affecting Corteva's stock price in the short term.
  • Debt-to-equity ratio of 0.10 may raise concerns about the company's leverage and financial health, impacting investor confidence.
  • The beta of 0.77 indicates that Corteva's stock price may be less volatile than the market average, potentially limiting short-term gains for investors seeking higher returns.

CTVA Forecast - Frequently Asked Questions

According to the research reports of 20 Wall Street equities research analysts, the average twelve-month stock price forecast for Corteva is $61.94, with a high forecast of $69.00 and a low forecast of $52.00.

20 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Corteva in the last year. There is currently 1 sell rating, 6 hold ratings and 13 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" CTVA shares.

According to analysts, Corteva's stock has a predicted upside of 7.08% based on their 12-month stock forecasts.

Over the previous 90 days, Corteva's stock had 1 downgrade by analysts.

Corteva has been rated by research analysts at Argus, JPMorgan Chase & Co., KeyCorp, Morgan Stanley, and Wells Fargo & Company in the past 90 days.

Analysts like Corteva more than other "consumer staples" companies. The consensus rating for Corteva is Moderate Buy while the average consensus rating for "consumer staples" companies is Hold. Learn more on how CTVA compares to other companies.


This page (NYSE:CTVA) was last updated on 9/25/2024 by MarketBeat.com Staff
From Our Partners